Health Canada

Health Canada

February 04, 2011 16:53 ET

Important Information: Additional Health Products Co-packaged with Recalled Alcohol Prep Pads

OTTAWA, ONTARIO--(Marketwire - Feb. 4, 2011) - Following our communication (http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2011/2011_04-eng.php) regarding COPAXONE co-packaged in a kit with Triad manufactured recalled alcohol prep pads, Health Canada is informing Canadians that other health products have been identified [SEE BELOW] that are co-packaged with these recalled alcohol prep pads.

Alcohol prep pads closely resemble alcohol swabs and are used for the same purpose: to cleanse or disinfect a particular area of the body.

ICU Medical has initiated a voluntary recall of Orbit subcutaneous infusion sets due to the co-packaging of their product with Triad alcohol prep pads. This product is used in the treatment of diabetes and ICU Medical has informed Health Canada that they will no longer be co-packaging their infusion pumps with Triad alcohol prep pads.

Merck Canada Inc., in consultation with Health Canada, issued a notice to health care practitioners (http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/_2011/pegetron_2_hpc-cps-eng.php) and the Canadian public (http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/public/_2011/pegetron_2_pc-cp-eng.php) that PEGETRON® used in the treatment of adult patients with chronic hepatitis C. has been co-packaged with the recalled Triad pads. Merck Canada is advising consumers to not use the alcohol prep pads, labelled ALCO-PREP® Pre-injection cleansing swab, packaged with PEGETRON® REDIPEN® but to use alternative alcohol prep pads, or a sterile gauze pad and isopropyl alcohol (70%).

Canadians may wish to consult with their health care practitioner if they or any member of their family are currently using health products that are co-packaged with alcohol prep pads to determine if these prep pads are manufactured by Triad. Should any new information be identified, Health Canada will continue to update Canadians.

To report suspected adverse reaction to these or other health products, please contact the Canada Vigilance Program of Health Canada toll-free at 1-866-234-2345, or complete a Canada Vigilance Reporting Form and send to us using one of these methods:

  • Fax: 1-866-678-6789
  • Internet: www.healthcanada.gc.ca/medeffect
  • Mail: Canada Vigilance Program
    Marketed Health Products Directorate
    Ottawa, ON, Address Locator 0701E
    K1A 0K9

Egalement disponible en francais

Contact Information

  • Media Inquiries:
    Health Canada
    613-957-2983
    or
    Public Inquiries:
    613-957-2991
    1-866-225-0709